An interview with Mika Salminen on the European Joint Action HA-REACT
The Joint Action on HIV and Co-Infection Prevention and Harm Reduction (HA-REACT) addresses knowledge gaps in the prevention of HIV and co-infections including… Read more »
Prof Jeffrey V. Lazarus is on the faculty at the Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona and at CHIP, the Centre for Health and Infectious Disease Research and WHO Collaborating Centre on HIV and Viral Hepatitis at Rigshospitalet, the University of Copenhagen. He also serves as the Board Chair of AFEW International, a Board member of the EASL International Liver Foundation, a steering committee member of the HIV in Europe Initiative, the ACHIEVE Hepatitis Elimination coalition and of the European Commission’s joint action on HIV and hepatitis. He is a member of the BMC Editorial Advisory Group.
Latest posts by Jeffrey V. Lazarus (see all)
- The challenge of sustainable funding – Jurgita Poškevičiūtė on financing harm reduction in Lithuania - 7th March 2018
- Unlocking state money for harm reduction – Darko Antik on helping NGOs in Macedonia - 23rd February 2018
- Securing crucial funding for harm reduction in a challenging setting: Iva Jovović discusses LET, the quality-of-life improvement NGO in Croatia - 18th October 2017
A Fighter by Nature – Tatjana Reic and the Viral Hepatitis Story
The experts in the European Liver Patients Association (ELPA) Hep-CORE advisory group provide a window on the broad range of hepatitis activities and… Read more »
INHSU? Gesundheit!
Hepatology, Medicine and Policy editor-in-chief Jeffrey Lazarus shares some reflections during the 5th International Symposium on Hepatitis Care in Substance… Read more »
Packing for INHSU? Bring a health systems perspective!
In advance of the 5th International Symposium on Hepatitis Care in Substance Users in Oslo, Norway, the Editor-in-Chief of Hepatology, Medicine and Policy… Read more »
A clinician’s career in viral hepatitis: a powerful history and optimistic future
The experts in the European Liver Patients Association (ELPA) Hep-CORE advisory group provide a window on the broad range of hepatitis activities and… Read more »
Patient associations: a key catalyst for hepatitis advocacy and impact
The experts in the European Liver Patients Association (ELPA) Hep-CORE advisory group provide a window on the broad range of hepatitis activities and… Read more »
Changing to a holistic approach towards hepatitis policy
The experts in the European Liver Patients Association (ELPA) Hep-CORE advisory group provide a window on the broad range of hepatitis activities and… Read more »
Outside the biomedical box of hepatitis C research
The experts in the European Liver Patients Association (ELPA) Hep-CORE advisory group provide a window on the broad range of hepatitis activities and… Read more »
Snapshot from a revolution: ILC insights that caught my attention
Jeffrey V. Lazarus looks beyond the headlines to highlight some quietly important points that emerged at the recent International Liver Congress (April 13-17,… Read more »
The same debates, 25 years later
The experts in the European Liver Patients Association (ELPA) Hep-CORE advisory group provide a window on the broad range of hepatitis activities and… Read more »